PARP1 and pulmonary emphysema: However, in a study using a model of elastase-induced emphysema and chronic lung inflammation in mice, prolonged inhibition of PARP1/ARTD1 with olaparib reduced the number of macrophages in the bronco-alveolar lavage after 21 days of treatment when compared with the control group [49].